title: [Detection of protein p53 in the stool of patients with colorectal cancer].
abstract: OBJECTIVE
  Mutations of TP53, a tumor suppressor gene, are found in 60% to 70% of colorectal cancers. These mutations usually induce an overexpression caused by modification of the p53 protein conformation. The aim of this study was to investigate whether stool specimens of patients with colorectal cancer contain increased amounts of p53 protein.
  
  
  METHODS
  p53 protein was measured using a sandwich enzyme immunoassay in the stool specimens of 52 patients: 25 with colorectal cancer, 4 with colorectal adenomas and 23 apparently free of gastrointestinal disease. Results were expressed as pg/mg of total protein. The presence of fecal occult-blood was searched using Hemoccult II and Hemolex (an immunochemical assay for human hemoglobin).
  
  
  RESULTS
  Median concentrations of stool p53 protein were 16.6 pg/mg (range: 0-591 pg/mg) in patients with colorectal cancers, 39.1 pg/mg (range: 5-72 pg/mg) in patients with adenomas and 5.9 pg/mg (range: 0-65 pg/mg) in control subjects. Resection of colorectal cancers caused a marked decrease of stool p53 protein concentrations. When the cut-off value for stool p53 protein was set at 60 pg/mg of fecal protein (concentrations over the 95th percentile), the positivity of the assay was independent of tumor size and Astler-Coller stage, but weakly associated with rectal location of cancer. The sensitivity of stool p53 protein for colorectal cancer was 44%, and the specificity was 96%. In contrast, the sensitivity of Hemoccult II and Hemolex tests was 48% and 44%, whereas their specificity was 91% and 96%, respectively.
  
  
  CONCLUSIONS
  The detection of p53 protein is achievable in stool, but this assay is not more efficient than fecal occult blood tests for detection of colorectal cancer.
authors.affiliation: INSERM Unité 10, Hôpital Bichat, Paris.
authors.forename: P
authors.initials: P
authors.lastname: Jaïs
authors.forename: N
authors.initials: N
authors.lastname: Kapel
authors.forename: D
authors.initials: D
authors.lastname: Chosidow
authors.forename: N
authors.initials: N
authors.lastname: Rupaire
authors.forename: P
authors.initials: P
authors.lastname: Rougier
authors.forename: P
authors.initials: P
authors.lastname: Lasser
authors.forename: M
authors.initials: M
authors.lastname: Mignon
authors.forename: M J
authors.initials: MJ
authors.lastname: Lewin
authors.forename: J G
authors.initials: JG
authors.lastname: Gobert
mesh_terms: D000230:Adenocarcinoma / Q000737:chemistry* / Q000175:diagnosis / Q000601:surgery; D000368:Aged; D000369:Aged, 80 and over; D015179:Colorectal Neoplasms / Q000737:chemistry* / Q000175:diagnosis / Q000601:surgery; D004797:Enzyme-Linked Immunosorbent Assay; D005240:Feasibility Studies; D005243:Feces / Q000737:chemistry*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009780:Occult Blood; D011184:Postoperative Period; D012680:Sensitivity and Specificity; D016159:Tumor Suppressor Protein p53 / Q000032:analysis*
chemical_list: D016159:Tumor Suppressor Protein p53
vernacular_title: Détection de la protéine p53 dans les selles de malades atteints de cancer colo-rectal.